Top 10 T1D Research Breakthroughs of 2020
While COVID-19 has dominated the news in 2020, it’s also been a huge year for type 1 diabetes research. This year, we’ve made more progress than ever on our mission…
Talking T1D Research with Prof Tom Kay
Prof Tom Kay is Director of St Vincent’s Institute of Medical Research in Melbourne, and Principal Investigator of the recently launched BANDIT clinical trial. BANDIT is looking at a drug…
Talking with T1D Researchers: Highlights from IDS 2020
Every 18 months, the Immunology of Diabetes Society (IDS) Congress brings together the world’s brightest scientific minds to discuss the latest progress in understanding and treating T1D. This year’s virtual…
New clinical trial results: Hybrid closed-loop technology for adults with T1D
Results from a recently completed JDRF clinical trial have shown some big benefits to hybrid closed-loop technology. Published in the journal Diabetes Care, the results come from a trial led…
Research Roundup: 5 Top Stories from EASD Annual Meeting 2020
The European Association for the Study of Diabetes (EASD) annual meeting brings together the top researchers from around the world to discuss the latest findings in diabetes research. This year,…
The Australasian Diabetes Data Network (ADDN) appoints a new Medical Director
JDRF is pleased to announce the appointment of Prof Maria Craig in a new role as Medical Director of the Australasian Diabetes Data Network (ADDN). Prof Craig has a wealth…
The Research Pathway: Turning an Idea Into a T1D Breakthrough
You may have heard that getting a new T1D treatment or device to market can take around 12 to 15 years. This is because there’s a huge amount of work…
How Does a Clinical Trial Work?
Clinical trials are an essential part of T1D research. Before any new intervention – whether it’s a drug, device, or test – can be made available to the public, researchers…
